| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/28/2011 | US20110183009 Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182972 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 07/28/2011 | US20110182953 Polymorphic form of calcium acamprosate |
| 07/28/2011 | US20110182948 Method for treating disease characterized by plaque |
| 07/28/2011 | US20110182947 Hydrogel-driven drug dosage form |
| 07/28/2011 | US20110182943 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 07/28/2011 | US20110182928 Vaccine against amyloid folding intermediate |
| 07/28/2011 | US20110182918 Personalized drug treatment and smoking cessation kit and method |
| 07/28/2011 | US20110182917 Therapeutic or prophylactic agent for generalized pain syndrome |
| 07/28/2011 | US20110182912 Agents and methods for denervation |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182883 Novel gene disruptions, compositions and methods relating thereto |
| 07/28/2011 | US20110182853 Platelet derived growth factor (pdgf)-derived neurospheres define a novel class of progenitor cells |
| 07/28/2011 | US20110182849 Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
| 07/28/2011 | US20110182831 Systems and methods used in conjunction with nicotine vaccines for effecting cessation of tobacco use |
| 07/28/2011 | US20110182818 Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| 07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |
| 07/28/2011 | US20110182809 Method of Promoting Neurogenesis |
| 07/28/2011 | DE102010001179A1 Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen Guluronsäure- use of hydrogels based and / or mannuronsäurehaltiger polysaccharides for treatment of damage to the nervous system, for the promotion of nerve growth, for the treatment of neurodegenerative diseases and for the cultivation of neurons |
| 07/28/2011 | CA2792993A1 Special composition for the use thereof as a drug |
| 07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | CA2787756A1 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 07/28/2011 | CA2787684A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2787173A1 Methods and compositions for improved nerve conduction velocity |
| 07/28/2011 | CA2786666A1 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad) |
| 07/28/2011 | CA2786520A1 Pyrazine derivatives |
| 07/28/2011 | CA2785173A1 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| 07/28/2011 | CA2782588A1 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | CA2781733A1 Delivery system for diagnostic and therapeutic agents |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2348042A1 Modified amyloid beta peptide |
| 07/27/2011 | EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348016A1 Phenyl pyrrole aminoguanidine derivatives |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347763A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation |
| 07/27/2011 | EP2347760A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 07/27/2011 | EP2346869A2 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |
| 07/27/2011 | EP2346863A2 N-sulfonamido polycyclic pyrazolyl compounds |
| 07/27/2011 | EP2346848A1 Quinazoline derivatives as nk3 receptor antagonists |
| 07/27/2011 | EP2346832A1 Tricyclic compounds as glutamate receptor modulators |
| 07/27/2011 | EP2346828A1 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 07/27/2011 | EP2346826A2 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
| 07/27/2011 | EP2346825A2 Modulators of p2x3 receptor activity |
| 07/27/2011 | EP2346820A1 Oxycarbamoyl compounds and the use thereof |
| 07/27/2011 | EP2346526A2 Compositions of and methods of using ligand dimers |
| 07/27/2011 | EP2346506A1 Administration scheme of polar opioid metabolites for post-operative pain management |
| 07/27/2011 | EP2346500A1 Methods and compositions for improving cognitive function |
| 07/27/2011 | EP2125726B1 Spiro-piperidine derivatives |
| 07/27/2011 | EP2013213B1 Constrained compounds as cgrp-receptor antagonists |
| 07/27/2011 | EP1960428B1 Antibodies against amyloid beta with glycosylation in the variable region |
| 07/27/2011 | EP1855657B1 Dosage form containing oxycodone and naloxone |
| 07/27/2011 | EP1848695B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/27/2011 | EP1689713B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 07/27/2011 | EP1639139B1 Methods for the diagnosis and prognosis of alzheimer's disease |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | EP1461025B1 Treatment of parkinson's disease with cape |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1337855B1 Discordant helix stabilization for prevention of amyloid formation |
| 07/27/2011 | CN1974558B (+)-Meptazinol diligand derivative and/or its salt and the preparation process |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137862A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137861A Substituted alkyl pyrimidin-4-one derivatives |
| 07/27/2011 | CN102137854A 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases |
| 07/27/2011 | CN102137851A Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 07/27/2011 | CN102137842A Preparation of 3-pyrrole substituted 2-indolinone derivatives |
| 07/27/2011 | CN102137840A Gabapentin enacarbil salts and processes for their preparation |
| 07/27/2011 | CN102137669A Pharmaceutical compositions comprising gamma secretase modulators |
| 07/27/2011 | CN102137656A Pharmaceutical formulation of ketorolac for intranasal administration |
| 07/27/2011 | CN102134267A Novel dehydropachymic acid |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134214A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 07/27/2011 | CN102133406A Oil-phase preparation for opiates medicaments and preparation method thereof |
| 07/27/2011 | CN102133351A Pharmaceutical composition for treating Alzheimer's disease and preparation method thereof |
| 07/27/2011 | CN102133347A Drug for treating neurogenic headache |
| 07/27/2011 | CN102133346A Pulse releasing oral medicinal preparation containing ligusticum wallichii and rhizoma gastrodiae |
| 07/27/2011 | CN102133344A Health-care medicinal liquor |
| 07/27/2011 | CN102133339A Traditional Chinese medicine preparation for treating migraine |
| 07/27/2011 | CN102133331A Capsule with function of improving sleeping quality and preparation process |
| 07/27/2011 | CN102133320A Medicament for treating anhypnia |
| 07/27/2011 | CN102133290A Application of invigorator tea pill in electromagnetic radiation protection |
| 07/27/2011 | CN102133284A Pain killer for relieving pain of tumor patient |
| 07/27/2011 | CN102133278A Preparation method of 98% of paeoniflorin radix in radix paeoniae alba extract |
| 07/27/2011 | CN102133258A Extracting and purifying process of pongamia pinnata flavonoids |
| 07/27/2011 | CN102133243A Folium ginkgo extract containing 6-hydroxykynurenic acid |
| 07/27/2011 | CN102133242A Tuckahoe extract and preparation method thereof |
| 07/27/2011 | CN102133232A Cobra venom physical modification method and application in preparation of analgesia or immunosuppressive drugs |
| 07/27/2011 | CN102133216A Combined medicine for curing treatment-resistant depression and applications thereof |